- Home
- WDAY vs GSK Comparison
WDAY vs GSK Comparison
Compare WDAY & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDAY
- GSK
- Stock Information
- Founded
- WDAY 2005
- GSK 1715
- Country
- WDAY United States
- GSK United Kingdom
- Employees
- WDAY N/A
- GSK N/A
- Industry
- WDAY EDP Services
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- WDAY Technology
- GSK Health Care
- Exchange
- WDAY Nasdaq
- GSK Nasdaq
- Market Cap
- WDAY 68.6B
- GSK 74.6B
- IPO Year
- WDAY 2012
- GSK N/A
- Fundamental
- Price
- WDAY $256.39
- GSK $36.64
- Analyst Decision
- WDAY Buy
- GSK Hold
- Analyst Count
- WDAY 29
- GSK 4
- Target Price
- WDAY $292.00
- GSK $47.00
- AVG Volume (30 Days)
- WDAY 2.1M
- GSK 5.2M
- Earning Date
- WDAY 02-25-2025
- GSK 02-05-2025
- Dividend Yield
- WDAY N/A
- GSK 4.21%
- EPS Growth
- WDAY 2264.72
- GSK N/A
- EPS
- WDAY 6.03
- GSK 0.78
- Revenue
- WDAY $8,157,000,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- WDAY $18.28
- GSK $6.43
- Revenue Next Year
- WDAY $13.15
- GSK $5.34
- P/E Ratio
- WDAY $42.86
- GSK $23.15
- Revenue Growth
- WDAY 16.80
- GSK 3.46
- 52 Week Low
- WDAY $199.81
- GSK $31.72
- 52 Week High
- WDAY $311.28
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- WDAY 45.06
- GSK 58.60
- Support Level
- WDAY $255.24
- GSK $36.35
- Resistance Level
- WDAY $262.77
- GSK $37.22
- Average True Range (ATR)
- WDAY 7.20
- GSK 0.62
- MACD
- WDAY -0.94
- GSK 0.04
- Stochastic Oscillator
- WDAY 7.18
- GSK 65.58
About WDAY Workday Inc.
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.